JAZZ
Jazz Pharmaceuticals PLC
NASDAQ: JAZZ · HEALTHCARE · BIOTECHNOLOGY
$199.92
-1.99% today
Updated 2026-04-29
Market cap
$12.54B
P/E ratio
—
P/S ratio
2.94x
EPS (TTM)
$-5.83
Dividend yield
—
52W range
$98 – $207
Volume
1.0M
Jazz Pharmaceuticals PLC (JAZZ) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $164.78M | $214.57M | $207.55M | $117.50M | $107.40M | $135.73M | $253.57M | $1.97B | $2.24B | $3.34B | $3.36B | $4.80B | $5.12B | $5.20B | $5.54B | $6.54B | $12.30B | $10.84B | $11.39B | $12.01B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $31.38M | $91.56M | $116.09M | $44.00M | $36.95M | $74.46M | $199.13M | $551.57M | $864.62M | $1.02B | $1.26B | $748.07M | $968.28M | $1.23B | $1.63B | $2.84B | $2.61B | $2.61B | $3.44B | $4.63B |
| Total liabilities | $283.03M | $390.87M | $152.56M | $210.38M | $180.23M | $105.18M | $60.78M | $845.20M | $942.69M | $1.97B | $1.76B | $2.92B | $2.41B | $2.45B | $2.43B | $2.88B | $8.33B | $7.75B | $7.66B | $7.92B |
| Current liabilities | $23.34M | $30.52M | $36.86M | $173.49M | $59.24M | $59.94M | $52.87M | $191.54M | $204.03M | $216.80M | $226.64M | $257.41M | $293.95M | $345.49M | $364.49M | $653.75M | $809.30M | $933.19M | $1.54B | $1.04B |
| Long-term debt | $89.07M | $74.28M | $75.12M | — | $91.11M | $24.63M | $0.00 | $427.07M | $544.40M | $1.33B | $1.17B | $1.99B | $1.54B | $1.56B | $1.57B | $1.85B | $6.02B | $5.69B | $5.11B | $6.08B |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-118.25M | $-177.64M | $-316.47M | $-500.81M | $-507.64M | $-474.87M | $-349.88M | $-61.30M | $18.53M | $34.70M | $302.69M | $528.91M | $917.96M | $841.05M | $1.07B | $1.16B | $830.23M | $733.59M | $878.66M | $1.13B |
| Accounts receivable | $3.60M | $5.38M | $5.39M | $6.64M | $12.31M | $22.08M | $34.37M | $75.48M | $124.81M | $186.37M | $209.69M | $234.24M | $224.13M | $263.84M | $355.99M | $396.49M | $563.36M | $651.49M | $705.79M | $716.76M |
| Inventory | $3.26M | $3.03M | $2.21M | $4.79M | $3.43M | $5.05M | $3.91M | $26.52M | $28.67M | $30.04M | $19.45M | $34.05M | $43.24M | $52.96M | $78.61M | $95.40M | $1.07B | $714.06M | $597.04M | $480.44M |
| Goodwill | $38.88M | $38.21M | $38.21M | $38.21M | $38.21M | $38.21M | $38.21M | $442.60M | $450.46M | $702.71M | $657.14M | $893.81M | $947.54M | $927.63M | $920.02M | $958.30M | $1.83B | $1.69B | $1.75B | $1.72B |